207 related articles for article (PubMed ID: 26175634)
1. Target-specific oral anticoagulants: should we switch from warfarin?
Safavi-Naeini P; Saeed M
Tex Heart Inst J; 2015 Jun; 42(3):229-33. PubMed ID: 26175634
[No Abstract] [Full Text] [Related]
2. Warfarin for stroke prevention in atrial fibrillation: time to switch?
Ahmad Y; Lip GY
Int J Clin Pract; 2013 Jul; 67(7):603-5. PubMed ID: 23758442
[No Abstract] [Full Text] [Related]
3. New oral anticoagulants in elderly patients with atrial fibrillation.
Deedwania PC
Am J Med; 2013 Apr; 126(4):289-96. PubMed ID: 23369212
[TBL] [Abstract][Full Text] [Related]
4. Will oral antithrombin agents replace warfarin?
Sinnaeve PR; Van de Werf FJ
Heart; 2004 Aug; 90(8):827-8. PubMed ID: 15253941
[TBL] [Abstract][Full Text] [Related]
5. The need for new oral anticoagulants in clinical practice.
Hylek EM
J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
[TBL] [Abstract][Full Text] [Related]
6. Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment.
Hakalahti A; Uusimaa P; Ylitalo K; Raatikainen MJ
Europace; 2011 May; 13(5):640-5. PubMed ID: 21398311
[TBL] [Abstract][Full Text] [Related]
7. Warfarin in non-valvular atrial fibrillation.
Dalby AJ; Wessels P; Opie LH
S Afr Med J; 2013 Oct; 103(12):901-4. PubMed ID: 24300625
[TBL] [Abstract][Full Text] [Related]
8. Beyond warfarin: a patient-centered approach to selecting novel oral anticoagulants for stroke prevention in atrial fibrillation.
Patel KK; Mehdirad AA; Lim MJ; Ferreira SW; Mikolajczak PC; Stolker JM
J Hosp Med; 2014 Jun; 9(6):400-6. PubMed ID: 24715600
[TBL] [Abstract][Full Text] [Related]
9. Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves.
Marcy TR; Truong T; Rai A
Consult Pharm; 2015 Nov; 30(11):644-56. PubMed ID: 26629800
[TBL] [Abstract][Full Text] [Related]
10. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823
[TBL] [Abstract][Full Text] [Related]
11. New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation.
Ahmad Y; Lip GY; Apostolakis S
Expert Rev Cardiovasc Ther; 2012 Dec; 10(12):1471-80. PubMed ID: 23253272
[TBL] [Abstract][Full Text] [Related]
12. Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage.
Chao TF; Liu CJ; Liao JN; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chen TJ; Lip GY; Chen SA
Circulation; 2016 Apr; 133(16):1540-7. PubMed ID: 26969761
[TBL] [Abstract][Full Text] [Related]
13. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
Berman JP; Halperin JL
Hosp Pract (1995); 2013 Feb; 41(1):37-48. PubMed ID: 23466966
[TBL] [Abstract][Full Text] [Related]
14. Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants.
Turagam MK; Velagapudi P; Flaker GC
Clin Interv Aging; 2015; 10():1431-44. PubMed ID: 26366064
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
Crowther MA
Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
[TBL] [Abstract][Full Text] [Related]
16. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Selçuk H; Selçuk MT; Maden O
Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
[TBL] [Abstract][Full Text] [Related]
17. New oral anticoagulants: which one should my patient use?
Weitz JI; Gross PL
Hematology Am Soc Hematol Educ Program; 2012; 2012():536-40. PubMed ID: 23233631
[TBL] [Abstract][Full Text] [Related]
18. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
19. Transitions of care in patients receiving oral anticoagulants: general principles, procedures, and impact of new oral anticoagulants.
Johnson MP
J Cardiovasc Nurs; 2013; 28(1):54-65. PubMed ID: 23222178
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of new oral anticoagulants in patients with atrial fibrillation previously treated with warfarin: a meta-analysis of randomized controlled trials.
Fauchier L; Clementy N; Saint-Etienne C; Simeon E; Angoulvant D; Bernard-Brunet A
Int J Cardiol; 2014 Apr; 173(1):122-4. PubMed ID: 24636544
[No Abstract] [Full Text] [Related]
[Next] [New Search]
